GENinCode (LON:GENI) Trading 6% Higher – Time to Buy?

GENinCode Plc (LON:GENI)’s share price was up 6% during mid-day trading on Friday . The stock traded as high as GBX 1.25 and last traded at GBX 1.01. 24,361,582 shares traded hands during trading, an increase of 354% from the average session volume of 5,363,759 shares. The stock had previously closed at GBX 0.95.

GENinCode Trading Up 6.0%

The stock’s 50-day moving average is GBX 0.87 and its two-hundred day moving average is GBX 1.02. The stock has a market cap of £7.58 million, a P/E ratio of -0.48 and a beta of 0.56. The company has a debt-to-equity ratio of 117.74, a current ratio of 0.93 and a quick ratio of 15.88.

GENinCode (LON:GENI) last issued its quarterly earnings data on Monday, June 8th. The company reported GBX (2.08) earnings per share for the quarter. The firm had revenue of GBX 308 million for the quarter. GENinCode had a negative net margin of 185.47% and a negative return on equity of 409.40%. Equities research analysts anticipate that GENinCode Plc will post -7.1299999 EPS for the current year.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.